
Kovee Pharma Private Limited
Founded in 2017 and headquartered in Telangana, India.
Founded in 2017 and headquartered in Telangana, India.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U33309TG2017PTC117471
117471
Private Limited Indian Non-Government Company
31 May 2017
29 Sep 2018
31 Mar 2018
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lakshmikanth Enaganti ![]() | Managing Director | 31-May-2017 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kotireddy Kakumanu ![]() | Director | 31-May-2017 | Current |
Enhance accessibility to Kovee Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Kovee Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Kotireddy Kakumanu is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kovee Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kovee Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kovee Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kovee Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Kovee Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad.
Lakshmikanth Reddy Enaganti was appointed as a Managing Director was appointed as a Managing Director on 31 May 2017 & has been associated with this company since 7 years 11 months .
Kotireddy Kakumanu was appointed as a Director was appointed as a Director on 31 May 2017 & has been associated with this company since 7 years 11 months .
Kovee Pharma Private Limited was registered on 31 May 2017 with Roc Hyderabad & aged 7 years 11 months as per MCA records.
Kovee Pharma Private Limited was incorporated on 31 May 2017.
The authorized share capital of Kovee Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Kovee Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kovee Pharma Private Limited is 16-2-Sr/R8 Sirila Park Pride, Hydernagar India, Hyderabad, Telangana, 500049.
The corporate identification number (CIN) of Kovee Pharma Private Limited is U33309TG2017PTC117471 and the company number is 117471 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Kovee Pharma Private Limited was filed with the ROC on 31 Mar 2018.
Search company & director profiles for free and gain access to critical business data.